Rescue of haemopoiesis by a combination of growth factors including stem-cell factor

Lancet

Volumn 356, Issue 9238, 2000, Pages 1325-1326

  Blaise, D ^a   Faucher, C ^a   Vey, N ^a   Caraux, J ^b   Maraninchi, D ^a   Chabannon, C ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b Value and Access Amgen SAS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANCESTIM; ANTIBIOTIC AGENT; CARMUSTINE; CYTARABINE; CYTOKINE; ETOPOSIDE; MELPHALAN; METHYLPREDNISOLONE; MORPHINE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR;

ADULT; ARTICLE; BLOOD TOXICITY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKOCYTE COUNT; NEUTROPHIL; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

EID: 0034649054     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02820-8     Document Type: Article

References (5)

1. Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: Toxicity and antitumour activity in 26 patients with poor-risk malignancies
2. GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen
3. Administration of three cytokines instead of bone marrow transplantation in an HIV + patient with high-grade lymphoma
4. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: The number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery
5. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells